A-1 Ltd denies 20% stake acquisition in Yashvi Lifesciences

A-1 Limited has issued a clarification regarding a message on the Telegram channel 'Chase Alpha-SEBI REG' claiming the company acquired a 20% stake in Yashvi Lifesciences. A-1 Ltd categorically stated that this information is "completely false, baseless and fabricated." The company confirmed it has not acquired any stake in Yashvi Lifesciences, nor is any such proposal under consideration by its Board of Directors. A-1 Ltd also clarified it has no affiliation with the Telegram channel or its operators. The company condemned the dissemination of misleading information, which it believes aims to manipulate investor sentiment, and announced it would file a formal clarification on the BSE portal. Management is evaluating legal action against those responsible for spreading the rumors, reiterating its commitment to corporate governance and transparency.